A marine sponge Petrosia similis afforded two compounds which belongs to bis-quinolizidine alkaloids namely, petrosin (1) and petrosin-A (2), respectively. Petrosin (1) and petrosin-A (2) showed anti-HIV inhibition with IC 50 values of 41.3 and 52.9 m mm respectively. MAGI cell assays indicated that the compounds inhibited early steps of HIV replication. In extracellular HIV-1 Reverse Transcriptase inhibition assay petrosin and petrosin-A inhibited HIV-1 RT at 10.6 and 14.8 m mm. This is the first report of petroisns with anti-HIV activity.
Oceans are said to be the medicine chest of the future. The sessile nature of many marine organisms has evolved a unique repertoire of chemicals used for defense, as well as for communication and reproduction. Marine natural products have many uses in the fields of health sector as antiumourals, antivirals, and anti fungals. 2) In the continuing study on biologically active compounds from marine organisms 3) we investigated a bright blue colored sponge Petrosia similis from which we previously isolated many compounds. 4, 5) These include two bis-quinolizidine alkaloids namely, petrosin (1) and petrosin-A (2) which were isolated from this sponge for the first time. Previously petrosins from other sources were reported to have ichthyotoxic and vasodilative properties. 6) HIV is a pandemic disease which results in life threatening opportunistic infections and malignancies and remains one of the most urgent world health problems, being the first cause of death in Africa and the fourth leading cause of death worldwide. 7) Several useful drugs have been recently developed for the treatment of AIDS and the prevention of its onset in carriers of its causative virus, human immunodeficiency virus (HIV). However the rapid appearance of HIV strains resistant to the currently available drugs suggests that the effective treatment of this disease require innovative drugs having diverse mechanisms of anti-HIV activity. Also many of these drugs have severe side effects like inhibition of haemopoetic system making it essential to develop new effective drugs with less toxicity.
In this study, we have examined the anti-HIV activity of petrosins, isolated from the sponge Petrosia similis for the first time. Compounds 1 and 2 showed potential anti-HIV activity. Additionally we also elucidated the mechanism of inhibitory action.
MATERIALS AND METHODS

Animal Material
The sponge Petrosia similis (IIC-349) was collected from the Mandapam coast (N 9°18Ј, E 79°08Ј), of the Gulf of Mannar, Tamilnadu, India during the month of October 1999. The freshly collected sponge specimens were soaked in methanol at the site of collection until workup.
Extraction and Isolation The initial methanol was removed and the sponge (500 g) was extracted with 1 : 1 dichloromethane : methanol. The combined extract was concentrated under reduced pressure to a predominantly aqueous suspension and extracted into ethyl acetate. The organic soluble extract (10 g) was subjected to gel filtration chromatography (Sephadex LH-20, 1 : 1 CH 2 Cl 2 -MeOH, 47 mmϫ830 mm, 25 ml each fraction of 40 total continuous fractions) followed by silica gel chromatography using hexane through hexane-ethyl acetate mixtures, to ethyl acetate, afforded petrosin (100 mg) and petrosin-A (70 mg). Chemical structures of these compounds were established by comparing the NMR data ( 1 H-, 13 C-NMR, 1 H-1 H COSY, HMQC) and physical properties ([a] D , mp) with those of reported compounds. 8, 9) Cells and Virus MT2 cells 10) were obtained from National AIDS Research Institute, Pune, India, and were maintained in RPMI 1640 (Sigma cat # R4130) containing 10% Fetal Bovine Serum (Sigma cat # F2442) and PenicillinStreptomycin suspension (Sigma cat # P0781) at 37°C in a 5% CO 2 humidified atmosphere incubator (Forma scientific company, U.S.A.) and splitted twice a week. Cultures were maintained in complete medium for the whole experiment.
The recombinant human cell line Hela-CD4-LTR-b-Gal or "MAGI" (Multinuclear Activation of Galactosidase Indicator) was obtained through the AIDS Research and Reference Reagent Program (Cat # 1470). MAGI cells were maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal calf serum, G418 and hygromycin. Cells were maintained in this medium throughout the experiment.
HIV-1 MN is a syncytium inducing X4 strain obtained from AIDS Reference and Reagent Program (Cat # 317) as culture supernatant. MT2 cells were infected with HIV-1 MN and the culture supernatant obtained was used as virus stock as de-scribed by Richman. 11) Virus stock was titrated by end point dilution of the cytopathogenic effects (CPE) in MT2 cells, and the p24 antigen concentration in the supernatant was measured by ELISA (SAIC, Frederick).
Anti-HIV Activity. Screening Test for Inhibition of Anti-HIV Activity As soon as MT2 cells were infected with HIV-1, the virus grows rapidly and in 4-7 d most of the MT2 cells are eradicated. We first assayed the inhibitory effect of each compound on HIV-1 MN replication by the following procedure.
MT2 cells (1.5ϫ10 5 /ml) were adsorbed with an infectious dose of 2 ng of p24/well for 1 h at 37°C and were then washed with culture medium. The HIV infected cells were suspended in 200 ml of culture medium containing the test compound in half dilutions starting from 100 mM in a flatbottomed 96 well culture plate for 7 d. The cultured cells were microscopically examined daily to determine the presence or absence of cytopathogenic effects (CPE). The toxicity of the compounds was tested by the MTT method.
Cytotoxic Activity The cytotoxicity of the compounds was tested by the MTT cytotoxicity assay.
12) The assay was performed in a flat-bottomed 96 well microtitre plate. The MT2 cell line was cultured in RPMI 1640 (Sigma cat # R4130) with 10% FBS (Sigma cat # F2442). About 5ϫ10 4 cells/well were exposed to various concentrations of the petrosin and petrosin A. After 24 h of incubation MTT (Sigma cat # M5655) was added to achieve a final concentration of 0.5-1 mg/ml. After 1 h of incubation at 37°C, the culture plates were briefly centrifuged and 150 ml of the medium is carefully removed without disturbing the cells. The formazan crystals were dissolved by addition of acidified isoproponal (0.04 M HCl in isoproponal). A purple-blue formazan precipitate will form in wells containing viable, proliferating cells. In wells with nonviable cells the culture medium remains yellow. The intensity of color is directly proportional to cell viability. The absorbance was read in a microprocessor controlled ELISA plate reader at 570 nm specific absorbance and background absorbance at 690 nm which is automatically subtracted from specific absorbance to give final absorbance. The CC 0 (Cytotoxic Concentration below which viability of cells is not effected) and CC 50 (Cytotoxic Concentration at which 50% of viability is reduced) were derived from a computer generated median plot of dose effect data.
Test for Inhibition of HIV-1 Replication in Cell Culture
The HIV drug susceptibility assay of the isolated compounds was performed using standard protocols. 13, 14) Briefly 4ϫ10 6 cells/well with ca. 100% viability were seeded in 96 well flat-bottomed microtitre culture plates. Cells were infected with HIV-1 MN at an infectious dose of 2 ng of p24/well (appropriate amount of virus required to cause complete pathogenicity at day 7). After incubation for 1 h at 37°C, the uninfected virus was eliminated by washing twice with complete medium. Infected cells were exposed to various concentrations of petrosin and petrosin A to reach a final volume of 200 ml/well. Cell and drug controls were included. AZT and Nevirapine were used as the standard anti-HIV agents. After 7 d of incubation the supernatants were collected and analyzed using p24 antigen assay capture kit (SAIC Frederick). The data given is an average of three independent experiments, each run in duplicate with a maximum deviation of 10%. The EC 50 (Effective Concentration at which there is a 50% inhibition of virus multiplication) was derived from a computer generated median effect plot of the dose effect data. The therapeutic index (TI) was defined as the CC 50 /EC 50 . In general TIϾ5 is considered to denote significant activity.
15)
Suppression of HIV-1 Induced Giant Cell Formation Uninfected and infected MT2 cells were cocultured in presence of petrosins or AZT in 48 well microtitre plates. Briefly cell suspensions (5ϫ10 5 cells/ml) were mixed in 1 : 10 (infected : uninfected) and incubated for 12 h. Corresponding control wells contained infected and uninfected cells. After incubation, the cultures were examined for presence or absence of giant cells.
The MAGI Cell Assay Inhibition of early steps of replication of HIV-1 can be assessed by the "MAGI" cell assay. For MAGI assays, 25 ml of virus-compound mixture was mixed with 225 ml of growth medium containing DEAE-dextran (15 mg/ml) and 50 ml was added to wells with confluent monolayers of MAGI (on a 96-well plate). At 2 h postinfection, an additional 200 ml of complete DMEM was added. After 3 d virucidal activity was measured by removal of the media, fixation with 1% formaldehyde and 0.2% glutaraldehyde, and staining with 5-bromo-4-chloro-3-indolyl b Dgalactopyranoside (X-Gal). We observed about 50 to 60 separate blue nuclei per well for the positive control. Comparison of the number of blue cells in wells infected with compound-treated virus to the number found in wells infected with untreated virus was used to determine residual viral infectivity (expressed as a percentage). Numerical data reported are the averages of three experiments, each run in duplicate. Controls were tested similarly.
Reverse Transcriptase Inhibition Activity Preparation of HIV-1 RT and extracellular reverse transcription activity of HIV-1 RT was performed as previously described. 16) Briefly recombinant HIV-1 RT was adjusted to 0.01 U/ml with a solution of 0.2 M phosphate buffer (pH 7.2), 50% glycerol, 2 mM DTT, and 0.02% of Triton ϫ100. A reaction mixture (20 ml) 50 mM Tris HCl (pH 8.3) 30 mM NaCl, 10 mM MgCl 2 , 5 mM DTT, 1.25 mg/ml Poly(rA). Oligo(dT) [12] [13] [14] [15] [16] [17] [18] as a templete primer, 250 nM dTTP, 100 nM H 3 dTTP (30 Ci /mmol), 0.01 U/ml RT, and 1 ml of test compound in DMSO, was incubated at 37°C for 1 h. Control reactions were performed under similar conditions without adding test compound and DMSO. The reaction was terminated by addition of 20 ml of 0.02 M EDTA. The resulting mixture was spotted on glass fiber filters (Whatman GF/A), and washed batchwise with 3 ml of Na 2 HPO 4 , distilled water 3 times, ethanol once and ether once. The disc is dried and immersed in 3 ml of scintillation fluid and amount of insoluble radioactivity determined. Adriamycin was used as a positive control with an IC 50 of 27 mM.
RESULTS AND DISCUSSION
The activity of petrosins for inhibition of HIV-1 replication in MT2 cells was examined. A primary screening test was conducted to test whether petrosins show any anti-HIV activity at various concentrations. Absence of cytopathogenic effects could be clearly observed in drug treated cells. However petrosin showed some toxicity at highest concentration tested (100 mM). Since the petrosins have shown anti-HIV ac-tivity in the screening test, the test compounds were further tested for cytotoxic activity and inhibition of HIV replication. Petrosin and petrosin A inhibited HIV-1 MN (IC 50 ) at 41.3 and 52.9 mM (Table 1) . Addition of inhibitors after inoculating and carefully washing the cells in order to monitor steps following virus entry, demonstrated not only entry events are blocked but further intracellular function are also impaired. The compounds could achieve IC 90 values below CC 50 of MT2 cells. (Table 2) . However reduction in cell number at IC 90 concentration indicated that the compounds either inhibited cell replication or killed the cells at that concentration. In order to prove that the observed antiviral effects are due to specific interactions rather than to an overall toxicity, the cytotoxic effects of petrosin and petrosin A were quantified. The fact that cell line could tolerate petrosin 4 times and petrosin A by 7 times the IC 50 demonstrate the specificity of inhibition.
The Mechanisms of Action CD4 cells infected with HIV-1 fuse with virus infected and uninfected cells together to form giant cells. These giant cells lose normal cell function and finally die. Destruction of CD4 positive cells affects the immunological defence mechanism inducing immunodeficiency in the patient. A drug that can inhibit this stage is likely to be highly effective.
In this experiment the inhibitory effect of cell to cell infection by petrosins was examined by use of HIV-1 induced giant cell formation system. The formation of giant cells was inhibited at 21.2 mM by petrosin and at 36.1 mM by petrosin A, which has correlated with the anti-HIV activity on HIV-1 MN replication. (Table 3 ). Therefore these compounds can be considered to block the binding and/or fusion of virus to cells.
Since the compounds inhibited giant cell formation and to locate the precise mechanism of action i.e., whether the compounds are acting in events before or after integration, a MAGI cell assay was performed. This assay monitors a subset of steps in viral replication cycle from initial fusion through integration and gene expression. (Fig. 1) . Thus it can be confident that petrosin are not acting in cell culture by inhibiting viral assembly or budding. The use of single step assay is more stringent than the popular MTT or XTT assays, which monitor viral replication over several replication cycles and have the potential to magnify small effects.
Furthermore the effects of petrosins on HIV-1 RT was evaluated. Petrosins inhibited HIV-1 recombinant reverse transcriptase in vitro at 10.6 and 14.8 mM, which is far lesser than the HIV-1 replication inhibition concentrations. The HIV-1 RT inhibition was concentration dependent and was observed for viral replication in a very similar manner. This suggests that HIV-1 RT inhibition has a significant role in HIV-1 replication inhibition by these compounds. (Table 3) Several drugs have been developed for treatment of AIDS and still many more are under development. However many of these drugs have severe side effects and the quick appearance of resistance has further complicated the problem. There is an urgent need to develop new and safer drugs for treatment of AIDS and HIV infection. The genus Petrosia has yielded a number of structurally diverse compounds. Many of these have been shown to be possessing biological activities. In search for novel anti-HIV and anti-cancer agents we have tested petrosin (1) and petrosin-A (2) for anti HIV EC 50 Concentration of drug that inhibits p24 antigen production in infected cells by 50% than in control without drug under similar conditions. EC 90 Concentration of drug that inhibits p24 antigen production in infected cells by 90% than in control without drug under similar conditions. The therapeutic index (TI) was defined as the CC 50 /EC 50 . activity. These compounds have shown significant anti-HIV activity. Petrosin was more active than petrosin-A, but was also more cytotoxic. In this paper we have shown that petrosins target atleast two central events in HIV replication cycle, interference with virus entry and inhibition of RT. Till to date only few marine anti-HIV compounds are reported. Also this is the first report on the anti-HIV activity of petrosins.
